Incidence of gastric side effects in controlled trials with unbranded aspirin and with various long-acting aspirin preparations.
Open Access
- 1 August 1978
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 37 (4) , 389
- https://doi.org/10.1136/ard.37.4.389-a
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Sulindac. Trials of a new anti-inflammatory drug.Annals of the Rheumatic Diseases, 1978
- A TRIAL OF MICRO-ENCAPSULATED AND ENTERICOATED ASPIRIN IN RHEUMATOID ARTHRITISRheumatology, 1976
- A DOUBLE-BLIND CROSS-OVER TRIAL OF PRENAZONE AND ASPIRIN IN THE MANAGEMENT OF RHEUMATOID ARTHRITISRheumatology, 1975
- Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1974
- Double-blind comparison of aspirin and 4-(acetamido) phenyl-2-acetoxy-benzoate (benorylate) in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1973
- Enteric‐Coated Microspherules. A Clinical Appraisal of Two Forms of AspirinThe Journal of Clinical Pharmacology and The Journal of New Drugs, 1969